A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

NCT06401044 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease

Interventions

DRUG: AMG 732
OTHER: Placebo

Sponsor

Amgen